The results of our study of the expression of ACE2 and TMPRSS2 suggest that smoking is unlikely to impact the likelihood of SARS-CoV-2 infection in the upper airways but that it may play a significant role in COVID-19 disease progression and severity. This evidence concerns the gene TMPRSS2 and COVID-19.